(PO25-14-22) Elective Surgery in Adult Patients With Excess Weight: Can Preoperative Dietary Interventions Improve Surgical Outcomes?

The ePoster content is available to NUTRITION 2022 LIVE ONLINE attendees who are logged in.<br><br>If you are registered, log in and then come back here to use this button.

Presenting Author(s)

Sally Griffin, APD, MNut&Diet, MMedResearch
– PhD Candidate and Dietitian, Queensland University of Technology, Carina, Queensland, Australia

Co-Author(s)

MP

Michelle Palmer, PhD
– Logan Hospital
ES

Esben Strodl, PhD
– Queensland University of Technology
RL

Rainbow Lai
– Logan Hospital
MB

Matthew Burstow, MD
– Logan Hospital
LR

Lynda Ross
– Queensland University of Technology

Disclosure(s):

Sally Griffin, APD, MNut&Diet, MMedResearch: No relevant financial relationship(s) with ineligible companies to disclose.

Objectives: Excess fat can complicate surgery and is a risk factor for postoperative complications, but the impact of intentional preoperative weight/fat loss on surgical outcomes is unclear. The objective of this systematic review was to summarize the literature regarding the impact of preoperative dietary interventions aimed at weight/fat loss on non-bariatric surgery outcomes.

Methods: PRISMA guidelines were followed, and four electronic databases were searched for non-bariatric surgery studies which evaluated surgical outcomes resulting from a preoperative dietary intervention which focused on weight loss, fat loss, or improvement of liver steatosis. Meta-analysis was unfeasible due to the extreme heterogeneity of variables.

Results: Fourteen studies, including five randomised controlled trials, were selected. Laparoscopic cholecystectomy, hernia repair, and liver resection were most studied. Diet duration was 1-68 weeks (median 9 weeks). Weight loss ranged from 3.3 to 55 pounds. Preoperative Very Low Calorie Diet (VLCD, ≤800kcal) or Low Calorie Diet (LCD, ≤900kcal) for 1-3 weeks had significant impact: reduction in blood loss for two liver resection and one gastrectomy study (-27 to -411mL, p < 0.05), and for laparoscopic cholecystectomy, reduction in 6 minutes in operating time (p < 0.05) and reduced difficulty of dissection/visualisation of Calot’s triangle (p < 0.05). There was no difference in length of stay (n=7 studies). No other results could be collated due to lack of control groups and common outcomes.

Conclusions: Preoperative VLCD or LCD for 1-3 weeks could reduce operating time and surgical difficulty for laparoscopic cholecystectomy and reduce blood loss for liver resection and gastrectomy. Impact for other surgery types is still unknown and requires further randomised controlled trials with common surgical outcomes to establish.

Funding Sources: The authors have no funding sources to declare.